CX3CL1 and atherosclerosis: The CX3CL1-CX3CR1 axis has demonstrated therapeutic potential in modulating inflammatory responses in models of atherosclerosis and cardiac hypertrophy, by limiting monocyte recruitment and reducing tissue damage (12, 13).